Related Experiment Video
Updated: Oct 2, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Autoimmune encephalitis: suspicion in clinical practice and mimics
Diogo Costa1, Ana Sardoeira1, Paula Carneiro2
1Department of Neurology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Abstract:
Despite the existence of well-established diagnostic criteria for autoimmune encephalitis, there are diseases capable of mimicking it. This study sought to retrospectively evaluate the reasons for testing and the final diagnosis of patients admitted to a Neurology ward tested for anti-NMDAR antibodies and estimate sensitivity and specificity of current diagnostic criteria. The threshold for testing was lower than that of the prevailing diagnostic criteria, and the proportion of autoimmune encephalitis mimics was high. Searching for alternative diagnoses is of pivotal importance in cases of autoimmune encephalitis suspicion, and diagnostic criteria may need expanding so that no autoimmune encephalitis is missed.
Insights
Many patients tested for anti-NMDAR antibodies have conditions mimicking autoimmune encephalitis. Current diagnostic criteria may need expansion to avoid missing actual autoimmune encephalitis cases.
Area of Science:
- Neurology
- Immunology
- Clinical Diagnostics
Background:
- Autoimmune encephalitis diagnosis relies on established criteria.
- Mimicking conditions can complicate accurate diagnosis.
- Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a significant autoimmune neurological disorder.
Purpose of the Study:
- To retrospectively analyze reasons for anti-NMDAR antibody testing in neurology patients.
- To determine the final diagnoses of patients tested for anti-NMDAR antibodies.
- To evaluate the sensitivity and specificity of current diagnostic criteria for autoimmune encephalitis.
Main Methods:
- Retrospective chart review of patients admitted to a Neurology ward.
- Analysis of indications for anti-NMDAR antibody testing.
- Review of final diagnoses, including autoimmune encephalitis and mimics.
- Assessment of diagnostic criteria performance.
Main Results:
- The threshold for testing anti-NMDAR antibodies was often below established diagnostic criteria.
- A high proportion of patients tested were ultimately diagnosed with conditions mimicking autoimmune encephalitis.
- Sensitivity and specificity analyses indicated potential limitations of current criteria.
Conclusions:
- Alternative diagnoses are crucial to consider when autoimmune encephalitis is suspected.
- Current diagnostic criteria for autoimmune encephalitis may require refinement or expansion.
- Improved diagnostic strategies are needed to ensure accurate identification and management of autoimmune encephalitis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

